Products Categories
CAS No.: | 30562-34-6 |
---|---|
Name: | Geldanamycin |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C29H40N2O9 |
Molecular Weight: | 560.645 |
Synonyms: | 2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione,9,13-dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, 9-carbamate (8CI);(+)-Geldanamycin;2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione,9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-,[8S-(4E,6Z,8R*,9R*,10E,12R*,13S*,14R*,16S*)]-;NSC 122750;NSC 212518;[8S-(4E,6Z,8R*,9R*,10E,12R*,13S*,14R*,16S*)]-9-[(Aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione; |
EINECS: | 999-999-2 |
Density: | 1.23 g/cm3 |
Melting Point: | 255 °C |
Boiling Point: | 783.9 °C at 760 mmHg |
Flash Point: | 427.9 °C |
Solubility: | DMSO: soluble |
Appearance: | yellow to orange powder |
Hazard Symbols: | T, Xi |
Risk Codes: | 36/37/38 |
Safety: | 26-27-36/37/39 |
PSA: | 163.48000 |
LogP: | 3.43750 |
EPA Genetic Toxicology Program.
The Geldanamycin, with the CAS registry number 30562-34-6, belongs to the product categories of Antibiotics; Antibiotics for Research and Experimental Use; Antitumors for Research and Experimental Use; Biochemistry; Macrolides (Antibiotics for Research and Experimental Use); Others (Antibiotics for Research and Experimental Use) ;Amines; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Heat Shock Protein 90. Its IUPAC name is called [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate. This chemical's classification codes are Anti-Infective Agents; Antibiotics, antineoplastic; Antineoplastic Agents; Antiviral Agents; Cysteine proteinase inhibitors; Drug / Therapeutic Agent; Enzyme inhibitors; Mutation data; Natural Product; Protease Inhibitors. The product should be sealed at temperature of -20 °C.
Physical properties of Geldanamycin: (1)ACD/LogP: 2.62; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 2; (4)ACD/LogD (pH 7.4): 2; (5)ACD/BCF (pH 5.5): 19; (6)ACD/BCF (pH 7.4): 18; (7)ACD/KOC (pH 5.5): 291; (8)ACD/KOC (pH 7.4): 267; (9)#H bond acceptors: 11; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 6; (12)Index of Refraction: 1.559; (13)Molar Refractivity: 146.759 cm3; (14)Molar Volume: 454.454 cm3; (15)Surface Tension: 51.436 dyne/cm; (16)Density: 1.234 g/cm3; (17)Flash Point: 427.864 °C; (18)Enthalpy of Vaporization: 129.976 kJ/mol; (19)Boiling Point: 783.862 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.
Geldanamycin is a benzoquinone ansamycin antibiotic that binds to Hsp90 (Heat Shock Protein 90) and alters its function. Geldanamycin induces the degradation of proteins that are mutated in tumor cells such as v-Src, Bcr-Abl and p53 preferentially over their normal cellular counterparts.
When you are using this chemical, please be cautious about it as the following:
This chemical may cause inflammation to the skin or other mucous membranes. It is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. Whenever you will contact it, please wear suitable protective clothing, gloves and eye/face protection.
You can still convert the following datas into molecular structure:
(1)SMILES: NC(=O)O[C@H]1C(/C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)C\C2=C(/OC)C(=O)\C=C(\NC(=O)C(\C)=C\C=C/[C@@H]1OC)C2=O
(2)InChI: InChI=1/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1
(3)InChIKey: QTQAWLPCGQOSGP-KSRBKZBZBP
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intravenous | > 4200ug/kg (4.2mg/kg) | Cancer Chemotherapy and Pharmacology. Vol. 36, Pg. 305, 1995. | |
mouse | LD | intravenous | > 50mg/kg (50mg/kg) | Cancer Chemotherapy and Pharmacology. Vol. 36, Pg. 305, 1995. | |
mouse | LD50 | intraperitoneal | 1mg/kg (1mg/kg) | "Compounds Available for Fundamental Research, Volume II-6, Antibiotics, A Program of Upjohn Company Research Laboratory." Vol. 2(6), Pg. -, 1971. | |
rat | LD50 | oral | 2500mg/kg (2500mg/kg) | Journal of Antibiotics. Vol. 23, Pg. 442, 1970. |